Arbutus Announces Intent to Repurchase Up to US$230 Million of its Common Shares Through Modified “Dutch Auction” Tender Offer

Neutral

AI Analysis

Summary

Arbutus Biopharma announced a modified Dutch auction tender offer to repurchase up to US$230 million of common shares at US$5.00-US$5.75 per share, expected to commence August 24, 2026 and expire September 29, 2026.

Importance:3/10

Sentiment:

0.00

share_repurchaseDutch_auctiontender_offercapital_allocation

Related Companies

$ABUS

Read the original article

Published by GlobeNewswire Pharma on August 21, 2026 11:30 AM

Read Original